13-cis-retinoic acid,Isotretinoin

13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.

Cross Reference

Introduction

To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 13-cis-retinoic acid,Isotretinoin?

13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin

MeSH term MeSH ID Detail
Acne Vulgaris D000152 35 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with 13-cis-retinoic acid,Isotretinoin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 13-cis-retinoic acid,Isotretinoin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

What genes are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 13-cis-retinoic acid,Isotretinoin

Download all related citations
Per page 10 20 50 100 | Total 2952
Authors Title Published Journal PubMed Link
Rowbotham SE et al. Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. 2010 Drug Metab. Dispos. pmid:20308471
Gencoglan G et al. Isotretinoin-induced effects of mast cells on wound healing. 2010 J Drugs Dermatol pmid:20941944
Rowbotham SE et al. Relevance of nonsynonymous CYP2C8 polymorphisms to 13-cis retinoic acid and paclitaxel hydroxylation. 2010 Drug Metab. Dispos. pmid:20421446
Schaffer LC et al. Psychiatric reactions to isotretinoin in patients with bipolar disorder. 2010 J Affect Disord pmid:19783054
Vestergaard P et al. High-dose treatment with vitamin A analogues and risk of fractures. 2010 Arch Dermatol pmid:20479294
NSAIDs, ACE inhibitors, angiotensin II receptor antagonists, and isotretinoin: still too many pregnant women exposed. 2010 Prescrire Int pmid:20455339
Koay DC et al. Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations. 2010 Breast Cancer Res. pmid:20696059
Smedje H et al. Onset of Kleine-Levin Syndrome in association with isotretinoin treatment. 2010 Acta Paediatr. pmid:20163374
Bagatin E et al. Dermabrasion for acne scars during treatment with oral isotretinoin. 2010 Dermatol Surg pmid:20180836
Karadag AS et al. Short-term isotretinoin treatment decreases insulin-like growth factor-1 and insulin-like growth factor binding protein-3 levels: does isotretinoin affect growth hormone physiology? 2010 Br. J. Dermatol. pmid:20128787
Kontaxakis VP et al. Genetic vulnerability and isotretinoin-induced psychiatric adverse events. 2010 World J. Biol. Psychiatry pmid:20109108
Penso-Assathiany D et al. [How far can we go in diseases that make life difficult: the example of disfiguring dermatoses]. 2010 Ann Dermatol Venereol pmid:20110076
Navarini AA et al. Control of widespread hypertrophic lupus erythematosus with T-cell-directed biologic efalizumab. 2010 Dermatology (Basel) pmid:20110637
Wong A et al. Isotretinoin-induced encephalopathy. 2010 J Dermatolog Treat pmid:20059367
Lott JP and Kovarik CL Availability of oral isotretinoin and terbinafine on the Internet. 2010 J. Am. Acad. Dermatol. pmid:20082897
Vuletic A et al. Antiproliferative effect of 13-cis-retinoic acid is associated with granulocyte differentiation and decrease in cyclin B1 and Bcl-2 protein levels in G0/G1 arrested HL-60 cells. 2010 Pathol. Oncol. Res. pmid:20084480
Chen S et al. Retinoids activate RXR/CAR-mediated pathway and induce CYP3A. 2010 Biochem. Pharmacol. pmid:19686701
DiPaola RS et al. A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899. 2010 J Transl Med pmid:20178647
McGrath EJ et al. A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms. 2010 Br. J. Dermatol. pmid:21137117
Liu QX et al. The cultivation and identification of tumor stem cells from neuroblastoma derived tumor spheres. 2010 Chin J Cancer pmid:21114922
Clouser MC et al. Dose response of retinol and isotretinoin in the prevention of nonmelanoma skin cancer recurrence. 2010 Nutr Cancer pmid:21058193
Wolkenstein P [Isotretinoin, depression and medias]. 2010 Ann Dermatol Venereol pmid:21095500
Cook D et al. Acne - best practice management. 2010 Aust Fam Physician pmid:20877771
Yu AL et al. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. 2010 N. Engl. J. Med. pmid:20879881
da Cunha Filho RR et al. Acute generalized exanthematous pustulosis induced by isotretinoin. 2010 Int. J. Dermatol. pmid:20883276
Swineford SL and Drucker CR Palliative treatment of paraneoplastic acanthosis nigricans and oral florid papillomatosis with retinoids. 2010 J Drugs Dermatol pmid:20865850
Bidoli P et al. Isotretinoin plus clindamycin seem highly effective against severe erlotinib-induced skin rash in advanced non-small cell lung cancer. 2010 J Thorac Oncol pmid:20871265
Mahé E and Beauchet A Dermatologists and the Internet. 2010 J. Am. Acad. Dermatol. pmid:20950742
Melnik BC The role of transcription factor FoxO1 in the pathogenesis of acne vulgaris and the mode of isotretinoin action. 2010 G Ital Dermatol Venereol pmid:20930691
Adams J The neurobehavioral teratology of retinoids: a 50-year history. 2010 Birth Defects Res. Part A Clin. Mol. Teratol. pmid:20865785
Schnopp C [Treatment of acne in childhood and adolescence]. 2010 MMW Fortschr Med pmid:21298978
Margolis DJ et al. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. 2010 Am. J. Gastroenterol. pmid:20700115
Goodfield MJ et al. Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010. 2010 Br. J. Dermatol. pmid:21250961
Rosen E et al. Giant cobblestone-like papillae during isotretinoin therapy. 2009 Sep-Oct Ocul. Immunol. Inflamm. pmid:19831559
Malvasi A et al. Possible long-term teratogenic effect of isotretinoin in pregnancy. 2009 Sep-Oct Eur Rev Med Pharmacol Sci pmid:19961047
Spillane AP and Hivnor CM Isotretinoin use in a case of chronic granulomatous disease. 2009 Nov-Dec Pediatr Dermatol pmid:20199463
Kwinter J and DeKoven J Generalized eruptive histiocytoma treated with isotretinoin. 2009 May-Jun J Cutan Med Surg pmid:19426623
Cumurcu T et al. Comparison of dose-related ocular side effects during systemic isotretinoin administration. 2009 Mar-Apr Eur J Ophthalmol pmid:19253234
Danopoulou I et al. Rapid improvement of extensive non-melanoma skin cancers with combination of 13-cis-retinoic acid and radiotherapy: report of three cases. 2009 Jul-Sep J BUON pmid:19810148
Antoniou C et al. Clinical and therapeutic approach to childhood acne: an update. 2009 Jul-Aug Pediatr Dermatol pmid:19689511
Kiliç E et al. Isotretinoin (13-cis-retinoic acid)-associated premature ventricular contractions. 2009 Jul-Aug Turk. J. Pediatr. pmid:19950851
Rivera R and Guerra A [Management of acne in women over 25 years of age]. 2009 Jan-Feb Actas Dermosifiliogr pmid:19268109
Park JR et al. Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group. 2009 Pediatr Blood Cancer pmid:18937318
Nelson AM et al. Isotretinoin temporally regulates distinct sets of genes in patient skin. 2009 J. Invest. Dermatol. pmid:18987667
Shale M et al. Isotretinoin and intestinal inflammation: what gastroenterologists need to know. 2009 Gut pmid:19433589
Zaidi Z Dispelling the myths and misconceptions of acne. 2009 J Pak Med Assoc pmid:19438124
Danby FW Oral isotretinoin, neuropathy and hypovitaminosis A. 2009 Clin. Exp. Dermatol. pmid:19438530
Hahm BJ et al. Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients. 2009 J. Dermatol. pmid:19382995
Gross H [Sunscreen, antibiotics, laser. What can you do against rosacea?]. 2009 MMW Fortschr Med pmid:20088315
Kim WG et al. Redifferentiation therapy with 13-cis retinoic acids in radioiodine-resistant thyroid cancer. 2009 Endocr. J. pmid:18854619